A-share Opening Express | The three major indices collectively opened higher, with the pharmaceutical biotechnology sector leading the way

Opening data

The Zhitong Finance App learned that on August 10, the Shanghai Index opened 0.10% higher to 3943.82 points, the Shenzhen Index opened 0.27% higher to 14348.95 points, the GEM index rose 0.11% to 3567.05 points, and the Science and Innovation 50 opened 0.22% lower to 1740.14 points. As of 9:35, a total of 3,053 companies in the two markets and the Beijing Stock Exchange had risen, 2,114 were down, and 372 were flat. The increase was highest: medical services, cinema lines, energy metals, chemical pharmaceuticals, biological products, etc.; the decline was the highest: communications, defense and military, computers, banking, general, etc.

Market conditions

On August 10, the three major A-share indices collectively opened higher. The Shanghai Index opened 0.10% higher to 3943.82 points, the Shenzhen Index opened 0.27% higher, the GEM Index opened 0.11% higher, and the Science and Innovation 50 opened 0.22% lower. Looking at Shenwan's tier-1 industry, the pharmaceutical and biological sector had the lead in opening up, rising 1.82%; sectors such as agriculture, forestry, animal husbandry and fishing, real estate, and environmental protection followed the rise. The communications sector opened down 0.40%, leading the decline in both markets, while sectors such as defense and military, computers, and banking weakened slightly. The number of companies rising in the entire market was over 3,000, rising and stopping 14, and falling to 3. The money-making effect was about 55%, and market sentiment was positive.

Overnight quick facts

The three major US stock indices collectively closed higher: On August 7 (last Friday), the three major US stock indices closed higher across the board. The Dow rose 0.28% to 54036.93 points, the S&P 500 rose 0.62%, and the NASDAQ rose 1.30%. The optical communications sector led the way, with Coherent up more than 13% and applied optoelectronics by more than 9%. The Nasdaq China Golden Dragon Index rose 0.77%, and most popular Chinese securities closed higher.

Beijing adjusted its housing purchase policy, and CPI rose moderately in July: On the evening of August 7, Beijing issued a notice reducing the social security or personal tax payment period for non-Beijing households to purchase commercial housing within the 5th Ring Road from 2 years to 1 year, which will take effect on August 8. The National Bureau of Statistics announced on August 9 that in July, CPI rose 0.5% year on year, core CPI rose 0.9% year on year, and overall prices maintained a moderate upward trend.

The Cambrian semi-annual report performance exceeded expectations, and DeepSeek predicted price increases: Cambrian revealed its semi-annual report on the evening of August 7. The first half of the year achieved operating income of 5.996 billion yuan, an increase of 108.13% year on year; net profit of 2,311 billion yuan, up 122.61% year on year, and stabilized at the 1 billion profit level for two consecutive quarters. DeepSeek announced on August 6 that it plans to increase overall API service pricing in the near future, and the official version of V4-Pro is about to be released.

Trend analysis

Today, the three major A-share indices collectively opened higher. The pharmaceutical biotechnology sector showed a pattern of structural differentiation due to continued strengthening of the CRO concept and the AI pharmaceutical theme leading the two markets. Communications, defense, and military industries saw a pattern of structural differentiation. Overnight, the three major US stock indices closed higher, NASDAQ rebounded more than 1%, and external risk appetite was fixed, forming a certain positive trend in the direction of A-share technology growth.

Judging from institutional consensus, most brokerage firms believe that A-shares are still in the overdraft and rebound stage. The varieties with large losses in the early period are more flexible, but the intensive disclosure period in mid-late August may be a key window for testing the success of the rebound. Repairs are progressing rapidly in electronics, innovative drugs, non-ferrous materials, etc., while communications, power equipment, etc. are lagging behind.

In the short term, against the backdrop of marginal restoration of market risk appetite, there is still room for interpretation, but we need to pay attention to the low opening performance of Science and Innovation 50 and the degree of differentiation in the weighted sector. The implementation of the mid-report results will be the core variable in choosing the next direction. Structural opportunities may focus on pharmaceuticals, AI applications, and resource products.